-
2025-522767-15-00
5
2026-01-27
Acute Myeloid Leukemia
-
2025-521514-26-00
5
2026-01-26
Persistent, Recurrent, or Newly Diagnosed Metastatic Cervical Cancer W
-
2023-508995-12-01
4
2025-12-24
Recurrent or metastatic non-small cell lung cancer (NSCLC)
-
2023-507525-42-00
5
2025-12-23
Endometrial cancer
-
2024-518899-31-00
5
2025-12-19
Variant or wild-type transthyretin (TTR) amyloid cardiomyopathy
-
2024-516253-49-01
4
2025-12-12
advanced/metastatic HER2-positive breast carcinoma
-
2025-521034-28-00
4
2025-12-05
Moderate to Severe Rheumatoid Arthritis (RA)
-
2024-518645-17-00
5
2025-10-07
Blood and lymphatic diseases
-
2023-508056-19-00
5
2025-10-02
HER2-Expressing (IHC 3+/IHC 2+), Mismatch Repair Proficient (pMMR), P
-
2023-508057-19-00
5
2025-09-23
Advanced HER2-expressing Biliary Tract Cancer
-
2024-512753-24-00
5
2025-08-05
Acute Myeloid Leukemia (AML)
-
2025-520557-36-00
1
2025-07-24
Advanced Solid Tumors
-
2025-521305-40-00
1
2025-07-22
Participants with Advanced Solid Tumors
-
2024-512011-45-00
7
2025-06-17
Unresectable locally advanced or metastatic colorectal cancer
-
2024-518359-47-00
10
2025-06-17
Acute Myeloid Leukemia
-
2023-507936-20-00
5
2025-05-05
Acute myeloid leukemia
-
2024-512733-32-00
5
2025-03-31
Acute Myeloid Leukemia (AML)
-
2024-515506-11-00
4
2025-03-24
Urothelial Carcinoma
-
2024-513317-12-00
5
2025-02-05
Pancreatic cancer
-
2023-506235-15-00
5
2024-11-07
Limited-Stage Small-Cell Lung Cancer (LS SCLC)
-
2023-504918-29-00
5
2024-08-22
Hormone receptor positive breast cancer
-
2023-505678-14-00
4
2024-08-19
Ulcerative Colitis
-
2023-504308-27-00
5
2024-06-06
non-squamous non-small cell lung cancer
-
2024-512294-26-00
1
2024-04-10
Advanced solid tumors